Christopher Patusky United Therapeutics Corp (UTHR) insider trading activity

Christopher Patusky is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 900 shares of UTHR, which is worth approximately $336,573. The most recent transaction as insider was on Sep 04, 2024, when has been sold 4,300 shares (Common Stock) at a price of $353.36 per share, resulting in proceeds of $1,519,448. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 900

0% 3M change

46.56% 12M change

Total Value Held $336,573

CHRISTOPHER PATUSKY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 04 2024	SELL Open market or private sale	$1,519,448 $353.36 p/Share	4,300 Reduced 82.69%	900 Common Stock
Sep 04 2024	BUY Exercise of conversion of derivative security	$754,349 $175.43 p/Share	4,300 Added 45.26%	5,200 Common Stock
Sep 03 2024	SELL Open market or private sale	$252,217 $360.31 p/Share	700 Reduced 43.75%	900 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$122,801 $175.43 p/Share	700 Added 30.43%	1,600 Common Stock
Jul 13 2024	BUY Exercise of conversion of derivative security	-	900 Added 50.0%	900 Common Stock
Jun 17 2024	SELL Open market or private sale	$591,000 $295.5 p/Share	2,000 Reduced 100.0%	0 Common Stock
Jun 17 2024	BUY Exercise of conversion of derivative security	$152,720 $76.36 p/Share	2,000 Added 50.0%	2,000 Common Stock
May 14 2024	SELL Open market or private sale	$346,298 $264.35 p/Share	1,310 Reduced 100.0%	0 Common Stock
May 14 2024	BUY Exercise of conversion of derivative security	$99,900 $76.26 p/Share	1,310 Added 50.0%	1,310 Common Stock
Feb 23 2024	SELL Open market or private sale	$376,320 $224.0 p/Share	1,680 Reduced 99.76%	4 Common Stock
Nov 07 2023	SELL Sale (or disposition) back to the issuer	$460,880 $230.44 p/Share	2,000 Reduced 54.29%	1,684 Common Stock
Nov 07 2023	BUY Exercise of conversion of derivative security	$176,060 $88.03 p/Share	2,000 Added 35.19%	3,684 Common Stock
Aug 17 2023	SELL Sale (or disposition) back to the issuer	$456,240 $228.12 p/Share	2,000 Reduced 54.29%	1,684 Common Stock
Aug 17 2023	BUY Exercise of conversion of derivative security	$176,060 $88.03 p/Share	2,000 Added 35.19%	3,684 Common Stock
May 10 2023	SELL Sale (or disposition) back to the issuer	$424,480 $212.24 p/Share	2,000 Reduced 54.29%	1,684 Common Stock
May 10 2023	BUY Exercise of conversion of derivative security	$176,060 $88.03 p/Share	2,000 Added 35.19%	3,684 Common Stock
Mar 15 2023	SELL Sale (or disposition) back to the issuer	$435,000 $217.5 p/Share	2,000 Reduced 54.35%	1,680 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	$176,060 $88.03 p/Share	2,000 Added 35.21%	3,680 Common Stock
Jan 03 2023	SELL Sale (or disposition) back to the issuer	$546,640 $273.32 p/Share	2,000 Reduced 54.35%	1,680 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$176,060 $88.03 p/Share	2,000 Added 35.21%	3,680 Common Stock
Nov 16 2022	SELL Sale (or disposition) back to the issuer	$391,575 $261.05 p/Share	1,500 Reduced 47.17%	1,680 Common Stock
Nov 16 2022	BUY Exercise of conversion of derivative security	$132,045 $88.03 p/Share	1,500 Added 32.05%	3,180 Common Stock
Aug 17 2022	SELL Sale (or disposition) back to the issuer	$664,890 $221.63 p/Share	3,000 Reduced 64.1%	1,680 Common Stock
Aug 17 2022	BUY Exercise of conversion of derivative security	$227,910 $75.97 p/Share	3,000 Added 48.54%	3,180 Common Stock
May 17 2022	SELL Sale (or disposition) back to the issuer	$381,980 $190.99 p/Share	2,000 Reduced 54.35%	1,680 Common Stock

Christopher Patusky

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account